Ready-to-drink shakes will lead GLP-1 meal replacement sales through 2036 as the leading product type, while high-protein positioning leads nutritional focus in 2026. The market is expected to be valued at USD 2.4 billion in 2026 and USD 10.9 billion by 2036, adding USD 8.5 billion over the forecast period.